Skip to Content

Delta 9 Cannabis Inc DLTNF

Morningstar Rating
$0.03 +0.01 (23.32%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

DLTNF is trading at a 40% discount.
Price
$0.02
Fair Value
$8.99
Uncertainty
Extreme
1-Star Price
$7.13
5-Star Price
$1.23
Economic Moat
Wtxr
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if DLTNF is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.03
Day Range
$0.030.04
52-Week Range
$0.010.06
Bid/Ask
$0.03 / $0.04
Market Cap
$7.17 Mil
Volume/Avg
116,231 / 357,670

Key Statistics

Price/Earnings (Normalized)
Price/Sales
0.09
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Delta 9 Cannabis Inc is a cannabis company. It sells cannabis products through its wholesale and retail sales channels and sells its cannabis grow pods to other businesses. The company's subsidiary, Delta 9 Bio-Tech Inc, is a licensed producer of medical and recreational cannabis and operates an 80,000-square-foot production facility in Winnipeg, Manitoba, Canada. The company owns and operates a chain of retail stores under the Delta 9 Cannabis store brand.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees
442

Valuation

Metric
DLTNF
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
0.09
Price/Cash Flow
Price/Earnings
DLTNF

Financial Strength

Metric
DLTNF
Quick Ratio
0.11
Current Ratio
0.49
Interest Coverage
−2.29
Quick Ratio
DLTNF

Profitability

Metric
DLTNF
Return on Assets (Normalized)
−22.25%
Return on Equity (Normalized)
−353.50%
Return on Invested Capital (Normalized)
−18.13%
Return on Assets
DLTNF
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ZTS
Zoetis Inc Class ALpbryjbpTnkq$77.2 Bil
MKKGY
Merck KGaA ADRPkbzvhkxlVjgqj$75.4 Bil
HLN
Haleon PLC ADRMndsqzdfNdp$38.1 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRGbrbtpqwKqqy$16.0 Bil
VTRS
Viatris IncTxrvyzmxsGlz$14.0 Bil
RDY
Dr Reddy's Laboratories Ltd ADRMknrnxlVbv$12.1 Bil
CTLT
Catalent IncPfjpfkjcwZlhryk$10.2 Bil
PRGO
Perrigo Co PLCFwlhzknkQft$4.3 Bil
CURLF
Curaleaf Holdings IncZrsvlxjwmFtl$4.0 Bil
PBH
Prestige Consumer Healthcare IncKzpkgynkXzjddg$3.6 Bil

Sponsor Center